Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Portsmouth, NH
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Portsmouth, NH
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Rochester, NY
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Raleigh, NC
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Salisbury, NC
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Columbus, OH
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
College Station, TX
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
San Antonio, TX
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris
Status: Enrolling
Updated:  5/24/2017
Dermatology Specialists PSC
mi
from
Louisville, KY
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris
Status: Enrolling
Updated: 5/24/2017
Dermatology Specialists PSC
mi
from
Louisville, KY
Click here to add this to my saved trials
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris
Status: Enrolling
Updated:  5/24/2017
Skin We Care Dermatology
mi
from
Mason, OH
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris
Status: Enrolling
Updated: 5/24/2017
Skin We Care Dermatology
mi
from
Mason, OH
Click here to add this to my saved trials
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
A Pilot Trial Assessing the Feasibility of Delivering Topical MTS-01 to Reduce Dermatitis in Patients Receiving Intensity Modulated Radiation With Concurrent 5-Fluorouracil and Mitomycin-C for Stage I-III Carcinoma of the Anal Canal
Status: Enrolling
Updated:  5/31/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
A Pilot Trial Assessing the Feasibility of Delivering Topical MTS-01 to Reduce Dermatitis in Patients Receiving Intensity Modulated Radiation With Concurrent 5-Fluorouracil and Mitomycin-C for Stage I-III Carcinoma of the Anal Canal
Status: Enrolling
Updated: 5/31/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated:  6/7/2017
Dermata Investigational Site
mi
from
Houston, TX
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated: 6/7/2017
Dermata Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated:  6/7/2017
Dermata Investigational Site
mi
from
Norfolk, VA
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated: 6/7/2017
Dermata Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Axis Clinical Trials
mi
from
Los Angeles, CA
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
SD Sports Medicine & Family Health Center
mi
from
San Diego, CA
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
SD Sports Medicine & Family Health Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Northwest Clinical Trials
mi
from
Boise, ID
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Altman Dermatology Assoc
mi
from
Arlington Heights, IL
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Altman Dermatology Assoc
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Scott Dlazer
mi
from
Buffalo Grove, IL
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Scott Dlazer
mi
from
Buffalo Grove, IL
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Shideler Clinical Research
mi
from
Carmel, IN
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Shideler Clinical Research
mi
from
Carmel, IN
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
The Southben Clinic
mi
from
South Bend, IN
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
The Southben Clinic
mi
from
South Bend, IN
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Grekin Skin Institute
mi
from
Warren, MI
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Grekin Skin Institute
mi
from
Warren, MI
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Minnesota Clinical Study Center
mi
from
Fridley, MN
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Academis Dermatology Assoc
mi
from
Albuquerque, NM
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Academis Dermatology Assoc
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Dermatology Consulting Services
mi
from
High Point, NC
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
MedaPhase, Inc.
mi
from
Newnan, GA
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
MedaPhase, Inc.
mi
from
Newnan, GA
Click here to add this to my saved trials
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated:  6/14/2017
Michigan Center for research Corp
mi
from
Clinton, MI
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses
Status: Enrolling
Updated: 6/14/2017
Michigan Center for research Corp
mi
from
Clinton, MI
Click here to add this to my saved trials
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Cumulative Irritation Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated:  6/19/2017
HillTop Research Corporation
mi
from
Scottsdale, AZ
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Cumulative Irritation Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated: 6/19/2017
HillTop Research Corporation
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated:  6/19/2017
HillTop Research Corporation
mi
from
Scottsdale, AZ
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated: 6/19/2017
HillTop Research Corporation
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
A Single-Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  6/22/2017
DermResearch, Inc.
mi
from
Austin, TX
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
A Single-Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 6/22/2017
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Center for Dermatology Clinical Research
mi
from
Fremont, CA
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
SD Sports Medicine & Family Health Center
mi
from
San Diego, CA
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
SD Sports Medicine & Family Health Center
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
The Center for Clinical and Cosmetic Research
mi
from
Aventura, FL
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
The Center for Clinical and Cosmetic Research
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Savin Medical Group Research Center
mi
from
Miami Lakes, FL
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Savin Medical Group Research Center
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Moore Clinical Research, Inc.
mi
from
Tampa, FL
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Moore Clinical Research, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Northwest Clinical Trials
mi
from
Boise, ID
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Altman Dermatology Associates
mi
from
Arlington Heights, IL
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Altman Dermatology Associates
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Shideler Clinical Research Center
mi
from
Carmel, IN
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Shideler Clinical Research Center
mi
from
Carmel, IN
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Bettencourt Skin Center
mi
from
Henderson, NV
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Bettencourt Skin Center
mi
from
Henderson, NV
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Union Square Dermatology
mi
from
New York, NY
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Union Square Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Dermatology Consulting Services
mi
from
High Point, NC
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Omega Medical Research, 400 Bald Hill Road, Warwick, RI 02886
mi
from
Warwick, RI
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Omega Medical Research, 400 Bald Hill Road, Warwick, RI 02886
mi
from
Warwick, RI
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Greenville Dermatology
mi
from
Greenville, SC
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Greenville Dermatology
mi
from
Greenville, SC
Click here to add this to my saved trials
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated:  6/26/2017
Dermatology Associates of Knoxville, PC
mi
from
Knoxville, TN
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Status: Enrolling
Updated: 6/26/2017
Dermatology Associates of Knoxville, PC
mi
from
Knoxville, TN
Click here to add this to my saved trials